Search for: "Immune Pharmaceuticals, Inc."
Results 1 - 20
of 344
Sorted by Relevance
|
Sort by Date
22 Jul 2018, 8:32 pm
IPR2016-01127, IPR2016-01128, IPR2016-01129, IPR2016-01130, IPR2016-01131, and IPR2016-01132 (and parallel IPRs filed by Petitioners Teva Pharmaceuticals USA, Inc. and Akorn, Inc., which had... [read post]
16 Feb 2007, 7:53 am
Singer In a February 14, 2006 press release, Idera Pharmaceuticals, Inc. announced that U.S. [read post]
14 Jun 2019, 12:24 pm
Mylan Pharmaceuticals Inc., 896 F.3d 1322 (Fed. [read post]
14 Jun 2019, 12:24 pm
Mylan Pharmaceuticals Inc., 896 F.3d... [read post]
31 Jul 2013, 7:04 pm
Wyeth Pharmaceuticals Inc., (now owned by Pfizer) a pharmaceutical company has agreed to pay $490.9 million to resolve the unlawful marketing of the prescription drug Rapamune. [read post]
22 Oct 2019, 9:15 am
Mylan Pharmaceuticals Inc., 896 F.3d 1322 (Fed. [read post]
31 Jul 2013, 7:04 pm
Wyeth Pharmaceuticals Inc., (now owned by Pfizer) a pharmaceutical company has agreed to pay $490.9 million to resolve the unlawful marketing of the prescription drug Rapamune. [read post]
31 Jul 2013, 7:04 pm
Wyeth Pharmaceuticals Inc., (now owned by Pfizer) a pharmaceutical company has agreed to pay $490.9 million to resolve the unlawful marketing of the prescription drug Rapamune. [read post]
31 Jul 2013, 7:04 pm
Wyeth Pharmaceuticals Inc., (now owned by Pfizer) a pharmaceutical company has agreed to pay $490.9 million to resolve the unlawful marketing of the prescription drug Rapamune. [read post]
18 Jan 2022, 2:29 pm
” Upon paying the settlement amount, Endo and two of its subsidiaries, Endo Pharmaceuticals Inc. and Endo Health Solutions Inc., will fully resolve Florida’s pending opioid-related claims. [read post]
23 Jul 2018, 2:38 pm
Mylan Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., AKORN, Inc. [read post]
5 Dec 2017, 7:40 am
Here are the amici curiae in the matter of Mylan Pharmaceuticals Inc. et al v. [read post]
25 Aug 2018, 9:09 pm
Teva Pharmaceuticals decision holding that the defense of tribal sovereign immunity does not apply to IPR proceedings; • Assessing the latest decisions on § 101 and their implications for branded pharmaceuticals; • Reviewing the state... [read post]
21 Aug 2018, 9:58 pm
Mylan Pharmaceuticals Inc., affirming the decision by the Patent Trial and Appeal Board (PTAB) of the U.S. [read post]
19 Sep 2019, 9:43 pm
Mylan Pharmaceuticals Inc.; Regents of the University of Minnesota v. [read post]
24 Oct 2018, 1:47 pm
Mylan Pharmaceuticals Inc., App. [read post]
24 Jun 2019, 10:00 pm
Mylan Pharmaceuticals, Inc., 896 F.3d 1322 (Fed. [read post]
31 Jul 2013, 8:04 pm
Wyeth Pharmaceuticals Inc., (now owned by Pfizer) a pharmaceutical company has agreed to pay $490.9 million to resolve the unlawful marketing of the prescription drug Rapamune. [read post]
25 Jul 2018, 12:47 pm
Mylan Pharmaceuticals Inc. et al., the U.S. [read post]
17 May 2018, 7:30 pm
Mylan Pharmaceuticals Inc. [read post]
